Influence on Effectiveness of Early Treatment with Anti-TNF Therapy in Rheumatoid Arthritis

ESCUDERO-VILAPLANA V; RAMÍREZ-HERRAIZ E; TROVATO-LÓPEZ N; ALAÑÓN-PLAZA E; BELLINI MJ; HERRANZ-ALONSO A ; BELLÓN-CANO JM ; MORELL-BALADRÓN A ; SANJURJO-SÁEZ M

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

CANADIAN SOC PHARMACEUTICAL SCIENCES

Año: 2012 vol. 15 p. 355 - 360

1482-1826

Purpose. To evaluate the association between starting early treatment with anti-TNF and effectiveness as well as the possibility of applying therapeutic spacing in daily practice in patients with rheumatoid arthritis (RA). Methods. Observational, retrospective study conducted in two universitary hospitals in Spain. RA patients who received the first anti-TNF (adalimumab: ADA, etanercept: ETN or infliximab: IFX) during the study period (October 2006-2010) were included. Demographic data, time since diagnosis, disease activity (DAS28-ESR) and anti-TNF dosage were analyzed. Therapeutic objective was defined as DAS28